COVID-19

Discover key reasons why pharmacies and labs should collaborate to enhance healthcare services, address provider shortages, and improve patient outcomes.

Research reveals that the HLA-B*15:01 allele may be linked to asymptomatic COVID-19 infection, potentially due to pre-existing T-cell immunity from previous coronaviruses.

Explore a study on the severity of COVID-19 in infants under 3 months, comparing symptoms, outcomes, and antimicrobial stewardship approaches in this vulnerable group

Explore the comparison of clinical sepsis phenotypes in critically ill COVID-19 patients and implications for predicting outcomes, treatment, and personalized medicine.

Learn about a study comparing baricitinib and dexamethasone for COVID-19 treatment in hospitalized patients, featuring insights from bioMérieux's Katherine Perez, PharmD.

Explore the impact of the COVID-19 pandemic on healthcare-associated infections with Lisa Sturm, as she shares insights on hospital-onset bloodstream infections and HAI reduction

Learn how genetic variants in severely ill COVID-19 patients may explain differences in illness severity.

Learn how RNA reference materials can standardize COVID-19 PCR tests, improving result comparability between labs and aiding in better assay harmonization

Discover how UPMC established a network for COVID-19 monoclonal antibody therapy across hospitals and facilities, overcoming logistical and infection prevention challenges

Learn about the long-term effects of COVID-19, including persistent symptoms and decreased quality of life, with insights from expert Christopher Bland, PharmD

IDSA updates COVID-19 guidelines to recommend tocilizumab for patients requiring oxygen and experiencing inflammation, following clinical trial results

Research at Massachusetts General Hospital reveals how severe COVID-19 linked to sepsis shows higher activity of MS1 cells

Learn about combo tests for COVID-19 and the flu, as experts like Dr. Mark Miller discuss their importance for accurate infectious disease management.

mRNA technology, behind COVID-19 vaccines, has the potential to revolutionize medicine and change the world of healthcare

Discover how a 1960s breakthrough in Yellowstone led to the development of PCR tests, crucial for diagnosing COVID-19 and revolutionizing biology.

Listen to Dr. Michael Osterholm, COVID-19 advisor, discuss SARS-CoV-2 immunity estimates, vaccine supply, and demand in this CIDRAP podcast episode.